USD 12.46
(-10.1%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 80.66 Million USD | -1.58% |
2022 | 80.07 Million USD | 107.6% |
2021 | 38.57 Million USD | 197.07% |
2020 | 12.98 Million USD | 32.73% |
2019 | 9.78 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 17.18 Million USD | 13.63% |
2024 Q1 | 15.58 Million USD | 3.81% |
2023 FY | 78.81 Million USD | -1.58% |
2023 Q4 | 15.01 Million USD | -29.67% |
2023 Q3 | 21.35 Million USD | -0.49% |
2023 Q1 | 22.31 Million USD | 8.27% |
2023 Q2 | 21.45 Million USD | -3.84% |
2022 Q3 | 22.16 Million USD | 15.87% |
2022 Q4 | 20.61 Million USD | -7.0% |
2022 FY | 80.07 Million USD | 107.6% |
2022 Q2 | 19.12 Million USD | 5.2% |
2022 Q1 | 18.18 Million USD | 0.05% |
2021 Q1 | 5.23 Million USD | 38.24% |
2021 FY | 38.57 Million USD | 197.07% |
2021 Q4 | 18.17 Million USD | 112.25% |
2021 Q3 | 8.56 Million USD | 29.48% |
2021 Q2 | 6.61 Million USD | 26.4% |
2020 Q4 | 3.78 Million USD | 13.26% |
2020 Q1 | 2.79 Million USD | 0.0% |
2020 Q3 | 3.34 Million USD | 8.9% |
2020 FY | 12.98 Million USD | 32.73% |
2020 Q2 | 3.06 Million USD | 9.89% |
2019 FY | 9.78 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Abbott Laboratories | 15.71 Billion USD | 99.487% |
Allurion Technologies Inc. | 120.57 Million USD | 33.099% |
Artivion, Inc. | 223.43 Million USD | 63.897% |
Avanos Medical, Inc. | 375.5 Million USD | 78.518% |
Butterfly Network, Inc. | 162.46 Million USD | 50.349% |
Butterfly Network, Inc. | 162.46 Million USD | 50.349% |
Bio-Rad Laboratories, Inc. | 1.04 Billion USD | 92.3% |
Boston Scientific Corporation | 7.47 Billion USD | 98.921% |
Perspective Therapeutics, Inc. | 17.42 Million USD | -362.906% |
CONMED Corporation | 564.24 Million USD | 85.704% |
Edwards Lifesciences Corporation | 3.09 Billion USD | 97.39% |
Paragon 28, Inc. | 210.1 Million USD | 61.606% |
Glaukos Corporation | 367.83 Million USD | 78.07% |
Globus Medical, Inc. | 887.16 Million USD | 90.907% |
Inspire Medical Systems, Inc. | 568.49 Million USD | 85.811% |
Integer Holdings Corporation | 250.95 Million USD | 67.857% |
Medtronic plc | 16.12 Billion USD | 99.5% |
Nevro Corp. | 389.36 Million USD | 79.283% |
Owlet, Inc. | 51.21 Million USD | -57.492% |
Penumbra, Inc. | 590.87 Million USD | 86.348% |
Smith & Nephew plc | 3.46 Billion USD | 97.673% |
Sonendo, Inc. | 68.46 Million USD | -17.821% |
STERIS plc | 1.4 Billion USD | 94.24% |
Stryker Corporation | 9.2 Billion USD | 99.124% |
Vapotherm, Inc. | 66.02 Million USD | -22.175% |
Zimmer Biomet Holdings, Inc. | 3.27 Billion USD | 97.538% |